다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Cell reports. Medicine, v.1 no.3, 2020년, pp.100040 -
Suthar, Mehul S. (Center for Childhood Infections and Vaccines) , Zimmerman, Matthew G. (Children’s Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, GA 30322, USA) , Kauffman, Robert C. (Center for Childhood Infections and Vaccines) , Mantus, Grace (Children’s Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, GA 30322, USA) , Linderman, Susanne L. (Center for Childhood Infections and Vaccines) , Hudson, William H. (Children’s Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, GA 30322, USA) , Vanderheiden, Abigail (Center for Childhood Infections and Vaccines) , Nyhoff, Lindsay (Children’s Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, GA 30322, USA) , Davis, Carl W. (Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329, USA) , Adekunle, Oluwaseyi (Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329, USA) , Affer, Maurizio (Center for Childhood Infections and Vaccines) , Sherman, Melanie (Children’s Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, GA 30322, USA) , Reynolds, Stacian (Center for Childhood Infections and Vaccines) , Verkerke, Hans P. (Children’s Healthca) , Alter, David N. , Guarner, Jeannette , Bryksin, Janetta , Horwath, Michael C. , Arthur, Connie M. , Saakadze, Natia , Smith, Geoffrey H. , Edupuganti, Srilatha , Scherer, Erin M. , Hellmeister, Kieffer , Cheng, Andrew , Morales, Juliet A. , Neish, Andrew S. , Stowell, Sean R. , Frank, Filipp , Ortlund, Eric , Anderson, Evan J. , Menachery, Vineet D. , Rouphael, Nadine , Mehta, Aneesh K. , Stephens, David S. , Ahmed, Rafi , Roback, John D. , Wrammert, Jens
AI-Helper
SummarySARS-CoV-2, the virus responsible for COVID-19, is causing a devastating worldwide pandemic, and there is a pressing need to understand the development, specificity, and neutralizing potency of humoral immune responses during acute infection. We report a cross-sectional study of antibody resp...
1 Bolles M. Donaldson E. Baric R. SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission Curr. Opin. Virol. 1 2011 624 634 22180768
2 Deming D. Sheahan T. Heise M. Yount B. Davis N. Sims A. Suthar M. Harkema J. Whitmore A. Pickles R. Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants PLoS Med. 3 2006 e525 17194199
3 Buchholz U.J. Bukreyev A. Yang L. Lamirande E.W. Murphy B.R. Subbarao K. Collins P.L. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity Proc. Natl. Acad. Sci. USA 101 2004 9804 9809 15210961
4 Bosch B.J. van der Zee R. de Haan C.A. Rottier P.J. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex J.？Virol. 77 2003 8801 8811 12885899
5 Hoffmann M. Kleine-Weber H. Schroeder S. Kruger N. Herrler T. Erichsen S. Schiergens T.S. Herrler G. Wu N.H. Nitsche A. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Cell 181 2020 271 280 32142651
6 Wang Q. Zhang Y. Wu L. Niu S. Song C. Zhang Z. Lu G. Qiao C. Hu Y. Yuen K.Y. Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2 Cell 181 2020 894 904 32275855
7 Tortorici M.A. Veesler D. Structural insights into coronavirus entry Adv. Virus Res. 105 2019 93 116 31522710
8 Li F. Li W. Farzan M. Harrison S.C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor Science 309 2005 1864 1868 16166518
9 Lu G. Hu Y. Wang Q. Qi J. Gao F. Li Y. Zhang Y. Zhang W. Yuan Y. Bao J. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26 Nature 500 2013 227 231 23831647
10 Walls A.C. Park Y.J. Tortorici M.A. Wall A. McGuire A.T. Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein Cell 181 2020 281 292 32155444
11 ter Meulen J. van den Brink E.N. Poon L.L. Marissen W.E. Leung C.S. Cox F. Cheung C.Y. Bakker A.Q. Bogaards J.A. van Deventer E. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants PLoS Med. 3 2006 e237 16796401
12 Harcourt J. Tamin A. Lu X. Kamili S. Sakthivel S.K. Murray J. Queen K. Tao Y. Paden C.R. Zhang J. Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States Emerg. Infect. Dis. 26 2020 1266 1273 32160149
13 Rockx B. Corti D. Donaldson E. Sheahan T. Stadler K. Lanzavecchia A. Baric R. Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge J.？Virol. 82 2008 3220 3235 18199635
14 Lee Y.L. Liao C.H. Liu P.Y. Cheng C.Y. Chung M.Y. Liu C.E. Chang S.Y. Hsueh P.R. Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients J.？Infect. 2020 10.1016/j.jinf.2020.04.019 Published online April 23, 2020
15 Okba N.M.A. Muller M.A. Li W. Wang C. GeurtsvanKessel C.H. Corman V.M. Lamers M.M. Sikkema R.S. de Bruin E. Chandler F.D. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients Emerg. Infect. Dis. 26 2020 9
16 Bloch E.M. Shoham S. Casadevall A. Sachais B.S. Shaz B. Winters J.L. van Buskirk C. Grossman B.J. Joyner M. Henderson J.P. Deployment of convalescent plasma for the prevention and treatment of COVID-19 J.？Clin. Invest. 130 2020 2757 2765 32254064
17 Shen C. Wang Z. Zhao F. Yang Y. Li J. Yuan J. Wang F. Li D. Yang M. Xing L. Treatment of 5 Critically Ill Patients with COVID-19 with Convalescent Plasma JAMA 323 2020 1582 1589 32219428
18 Liu W. Fontanet A. Zhang P.H. Zhan L. Xin Z.T. Baril L. Tang F. Lv H. Cao W.C. Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome J.？Infect. Dis. 193 2006 792 795 16479513
19 Amanat F. Krammer F. SARS-CoV-2 Vaccines: Status Report Immunity 52 2020 583 589 32259480
20 Smith K. Garman L. Wrammert J. Zheng N.Y. Capra J.D. Ahmed R. Wilson P.C. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen Nat. Protoc. 4 2009 372 384 19247287
21 Wrapp D. Wang N. Corbett K.S. Goldsmith J.A. Hsieh C.L. Abiona O. Graham B.S. McLellan J.S. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation Science 367 2020 1260 1263 32075877
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.